Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus.
Clin Exp Rheumatol
; 28(4): 525-31, 2010.
Article
em En
| MEDLINE
| ID: mdl-20659409
ABSTRACT
OBJECTIVES:
To determine whether immunological burden of autoantibodies as reflected by the number of cumulative antibodies present at inception and after 3 and 5 years is associated with or predicts subsequent disease activity and damage in lupus.METHODS:
Patients with SLE followed from inception at a single centre between 1992 and 2007 were included. Twelve autoantibodies were assayed in each patient at years 1, 3 and 5 of disease. The relationship between the burden of autoantibodies and outcomes, SDI (Systemic Lupus International Collaborative Clinics Damage Index), AMS (Adjusted Mean SLEDAI-2K) and AMS excluding anti-ds DNA (AMS-DNA) was evaluated as an association and as prediction. We determined the association between autoantibody burden and outcomes at years 1, 3 and 5 and the prediction using autoantibody burden at year 1 and year 3 to predict outcomes at years 3 and 5 respectively.RESULTS:
Between 1992 and 2007, 235 inception patients were identified. Of these, 223, 163 and 129 patients had 10 or more autoantibodies tested at years 1, 3 and year 5 following diagnosis respectively. There was no association between the burden at years 1, 3 and 5 and outcome measures at years 1, 3 and 5 respectively. Furthermore, burden of autoantibodies at years 1 and 3 did not predict the outcome measures at years 3 and 5 respectively.CONCLUSIONS:
Immunological burden in SLE at years 1, 3 or 5 as reflected by the number of autoantibodies found, was not associated with or predictive of subsequent disease activity or damage over time.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Autoanticorpos
/
Índice de Gravidade de Doença
/
Lúpus Eritematoso Sistêmico
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article